Skip to content

Serum Biomarkers for Migraine: A Prospective Registration Study

Amylin Concentration Affects Migraine Attack Frequency: A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073015
Enrollment
Unknown
Registered
2023-06-29
Start date
2023-06-30
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

Sponsors

The Affiliated Hospital of Yunnan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
9 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1) A previous clear diagnosis of migraine or clinical symptoms and imaging data that meet the migraine diagnostic criteria of the third edition of the International Classification of Headache Disorders (ICHD-3); 2) Have the ability to complete the «Headache Diary» independently or with the help of a guardian; 3) Sign informed consent; 4) Age not less than 9 years old and not more than 55 years old.

Exclusion criteria

Exclusion criteria: Patients will be excluded from this study in the presence of any of the following criteria at the discretion of the physician in charge: 1) severe systemic disease or disease that may alter neuropeptide levels, such as diabetes, active infection, recent myocardial infarction or surgery (within the past 3 months), renal failure, severe liver disease, inflammatory or neoplastic disease; 2) immunosuppressed patients, HIV-infected patients, drug or alcohol addicts who need to be treated with steroids or immunosuppressants; 3) Patients who used migraine prophylaxis or took opioids within 8 weeks prior to enrollment as recommended by Chinese, American or European migraine prevention and treatment guidelines; 4) Patients with severe mental disorders or intellectual disabilities

Design outcomes

Primary

MeasureTime frame
frequency of migraine attacks per month(days);frequency of headache attacks per month(days);migraine-specific quality of life questionnaire;

Secondary

MeasureTime frame
Number of migraine attacks per month;Number of headache attacks per month;Headache Impact Test-6;Migraine Disability Assessment Score;Patient Health Questionnaire-9;Athens Insomnia Scale;Perceived Stress Scale;

Countries

China

Contacts

Public ContactFanyi Kong

The Affiliated Hospital of Yunnan University

kfy9989@hotmail.com+86 152 8818 0792

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026